Quoin Pharmaceuticals Ltd ADR (QNRX): Next-Year EPS Estimate 59.08%
As of 2026-10-16, Quoin Pharmaceuticals Ltd ADR (QNRX) has a next-year EPS growth estimate of 59.08%. Featured in 4 EPS revision reports, most recently on 2026-07-02.
On 2026-10-12, analyst consensus for QNRX's next-year EPS growth shifted from 56.67% to 59.08% — a positive change of 2.41 percentage points. The revised estimate has been sustained across 5 subsequent trading sessions. Current-year growth is projected at 56.84%.
What's Driving This
The provided EPS data show a
Generated 2026-09-18 from news as of 2026-09-18
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 59.08%
- EPS growth this year
- 56.84%
- EPS next quarter (est)
- -$1.61
- Last price
- $3.90
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-10-16 | 59.08% | 56.84% | -$1.61 | $3.90 |
| 2026-10-15 | 59.08% | 56.84% | -$1.61 | $4.03 |
| 2026-10-14 | 59.08% | 56.84% | -$1.61 | $4.10 |
| 2026-10-13 | 59.08% | 56.84% | -$1.61 | $4.15 |
| 2026-10-12 | 59.08% | 56.84% | -$1.61 | $4.36 |
| 2026-10-11 | 56.67% | 58.72% | -$1.53 | $4.50 |
| 2026-10-10 | 56.67% | 58.72% | -$1.53 | $4.50 |
| 2026-10-09 | 56.67% | 58.72% | -$1.53 | $4.50 |
| 2026-10-08 | 56.67% | 58.72% | -$1.53 | $4.55 |
| 2026-10-07 | 56.67% | 58.72% | -$1.53 | $4.70 |
| 2026-10-06 | 56.67% | 58.72% | -$1.53 | $4.72 |
| 2026-10-05 | 56.67% | 58.72% | -$1.53 | $4.55 |
| 2026-10-04 | 56.67% | 58.72% | -$1.53 | $4.47 |
| 2026-10-03 | 56.67% | 58.72% | -$1.53 | $4.47 |
| 2026-10-02 | 56.67% | 58.72% | -$1.53 | $4.47 |
| 2026-10-01 | 56.67% | 58.72% | -$1.53 | $4.72 |
| 2026-09-30 | 56.67% | 58.72% | -$1.53 | $4.56 |
| 2026-09-29 | 56.67% | 58.72% | -$1.53 | $4.88 |
| 2026-09-28 | 56.67% | 58.72% | -$1.53 | $5.26 |
| 2026-09-27 | 56.67% | 58.72% | -$1.53 | $6.43 |
| 2026-09-25 | 56.67% | 58.72% | -$1.53 | $6.43 |
| 2026-09-24 | 56.67% | 58.72% | -$1.53 | $6.38 |
| 2026-09-23 | 56.67% | 58.72% | -$1.53 | $6.75 |
| 2026-09-22 | 56.80% | 55.84% | -$1.63 | $7.01 |
| 2026-09-21 | 56.80% | 55.84% | -$1.63 | $6.90 |
| 2026-09-20 | 56.80% | 55.84% | -$1.63 | $7.06 |
| 2026-09-18 | 56.80% | 55.84% | -$1.63 | $7.06 |
| 2026-09-17 | 56.80% | 55.84% | -$1.63 | $7.01 |
| 2026-09-16 | 56.80% | 55.84% | -$1.63 | $6.90 |
| 2026-09-15 | 56.80% | 55.84% | -$1.63 | $6.80 |
Reports Featuring QNRX
- 2026-07-02
Top Stock Gainers Driven by EPS Estimate Revisions: QNRX Up 40.9%, IOT Up 24% - July 2, 2026
- 2026-07-01
Top EPS Revision-Driven Movers: QNRX Surges +44.9% as NMAX Sees 376.9% Growth Estimate
- 2026-06-30
QNRX surges 48.9% as EPS revision signal precedes price breakout; HELP, ACMR also climb
- 2026-06-29
EPS Revision Bonanza: LILA +61%, HELP +47%, BDSX +42% Lead Surge
Recent News
- Quoin Pharmaceuticals Receives FDA Conditional Approval of QYLEKI as the Proposed Brand Name for QRX003 for Netherton SyndromeGlobeNewswire
- Quoin Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full-Year 2025 Financial ResultsGlobeNewswire
- Quoin Pharmaceuticals Provides Clinical and Regulatory Update from Constructive Type C Meeting with U.S. FDA for QRX003 in Netherton SyndromeGlobeNewswire
Screen Performance
Aggregate stats across all 2082 tickers our top-EPS-revision screen has flagged over the past 198 days.
- Median return since detection
- -3.0%
- % of tickers in the green
- 43%
- Median return on winners
- +21.5%
- Large revisions captured
- 1886
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
What is Quoin Pharmaceuticals Ltd ADR's next-year EPS growth estimate?▾
As of 2026-10-16, Quoin Pharmaceuticals Ltd ADR (QNRX) has a next-year EPS growth estimate of 59.08%, based on analyst consensus.
When was the latest EPS estimate revision for QNRX?▾
The most recent revision occurred on 2026-10-12, when analysts adjusted the next-year EPS growth estimate from 56.67% to 59.08%.
What sector and industry does Quoin Pharmaceuticals Ltd ADR belong to?▾
Quoin Pharmaceuticals Ltd ADR operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. QNRX appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Quoin Pharmaceuticals Ltd ADR (QNRX) appears here because it was detected by our daily top-EPS-revision-performer screen.